Researchers have identified a wide range of risk factors for young-onset dementia.
Pharmalittle: U.S. Senate eyes more policies for regulating PBMs; Novo claims most U.S. Wegovy patients pay less than $25 a month
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal